Actively Recruiting
The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica
Led by Uşak University · Updated on 2026-01-13
50
Participants Needed
1
Research Sites
29 weeks
Total Duration
On this page
Sponsors
U
Uşak University
Lead Sponsor
B
Balikesir University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The management of MP typically follows a conservative pathway, encompassing patient education, lifestyle modifications (e.g., avoidance of tight garments, weight loss), pharmacotherapy (such as neuropathic pain agents or corticosteroid injections), and physical therapy. However, evidence supporting the efficacy of these interventions is largely anecdotal or derived from low-quality studies, and a substantial proportion of patients experience persistent symptoms refractory to standard care. Therefore, the primary objective of this randomized, sham-controlled, assessor-blinded study is to investigate the efficacy of HPLT as an adjunct to standard conservative care on pain intensity, sensory symptoms, and functional capacity in patients with chronic Meralgia Paresthetica. The investigators hypothesize that patients receiving active HPLT will demonstrate significantly greater improvements in these outcomes compared to those receiving a sham laser procedure
CONDITIONS
Official Title
The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18-65 years
- Clinical diagnosis of Meralgia Paresthetica based on burning pain, tingling, numbness in the lateral thigh, tenderness near the anterior superior iliac spine, and positive pelvic compression or Tinel's test
- Symptoms lasting at least 3 months
- Baseline pain intensity of 4 or higher on the Numeric Rating Scale
You will not qualify if you...
- Secondary Meralgia Paresthetica due to pelvic surgery, trauma, or tumor confirmed by imaging
- Significant lumbar radiculopathy at L1-L2
- Blood clotting disorders or use of blood thinners
- Pregnancy
- Skin disease or infection in the treatment area
- Presence of a cardiac pacemaker
- Severe cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Usak University
Uşak, Turkey (Türkiye), 64200
Actively Recruiting
Research Team
A
Ali Y Karahan, Prof.
CONTACT
E
Ender Salbas, Asst. Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here